Immediate Impact

4 from Science/Nature 67 standout
Sub-graph 1 of 24

Citing Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
E-Tattoos: Toward Functional but Imperceptible Interfacing with Human Skin
2024 Standout
2 intermediate papers

Works of T. Piskáčková being referenced

Association Screening in the Epidermal Differentiation Complex (EDC) Identifies an SPRR3 Repeat Number Variant as a Risk Factor for Eczema
2011

Author Peers

Author Last Decade Papers Cites
T. Piskáčková 64 53 12 42 6 150
Peter T. Symanowicz 31 12 18 11 7 184
Bani Kaur Suri 34 51 5 63 7 191
Clive Hayward 38 11 2 73 6 175
Nestor González Roldán 11 20 5 64 7 187
Sarah De Schryver 10 36 3 138 10 167
Rebecca Willaert 13 27 31 13 8 176
Ravinder Atkar 6 43 12 10 10 134
Ayako Matsuki 17 14 3 32 6 206
Sandrine Quemener 16 17 3 15 7 173
Vidya Raman 84 3 3 21 7 175

All Works

Loading papers...

Rankless by CCL
2026